Exicure Inc. (NASDAQ: XCUR) stock jumped 25.63% on Friday to $2.50 against a previous-day closing price of $1.99. With 13.25 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.43 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $3.2376 whereas the lowest price it dropped to was $2.1000. The 52-week range on XCUR shows that it touched its highest point at $45.90 and its lowest point at $1.49 during that stretch. It currently has a 1-year price target of $93.75. Beta for the stock currently stands at 1.31.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of XCUR was up-trending over the past week, with a rise of 54.32%, but this was up by 24.38% over a month. Three-month performance dropped to -41.07% while six-month performance fell -65.92%. The stock lost -94.09% in the past year, while it has lost -58.77% so far this year.
Float and Shares Shorts:
At present, 4.03 million XCUR shares are outstanding with a float of 3.60 million shares on hand for trading. On Jul 14, 2022, short shares totaled 0.12 million, which was 2.37% higher than short shares on Jun 14, 2022. In addition to Dr. Matthias G. Schroff Ph.D. as the firm’s CEO, Pres & Director, Mr. Brian C. Bock serves as its Special Advisor.
Through their ownership of 16.32% of XCUR’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 542.15% of XCUR, in contrast to 155.70% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in XCUR with 256.87% of the stake, Tybourne Capital Management holds 195,208 shares worth 195,208. A second-largest stockholder of XCUR, The Vanguard Group, Inc., holds 91,424 shares, controlling over 120.30% of the firm’s shares. Carlson Capital LP is the third largest shareholder in XCUR, holding 46,666 shares or 61.41% stake. With a 71.95% stake in XCUR, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 54,676 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 45.82% of XCUR stock, is the second-largest Mutual Fund holder. It holds 34,823 shares valued at 75218.0. Fidelity Extended Market Index Fu holds 16.88% of the stake in XCUR, owning 12,827 shares worth 27706.0.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for XCUR since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With XCUR analysts setting a high price target of $7.50 and a low target of $7.50, the average target price over the next 12 months is $7.50. Based on these targets, XCUR could surge 200.0% to reach the target high and rise by 200.0% to reach the target low. Reaching the average price target will result in a growth of 200.0% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. XCUR will report FY 2022 earnings on 03/09/2023. Analysts have provided yearly estimates in a range of -$4.20 being high and -$4.20 being low. For XCUR, this leads to a yearly average estimate of -$4.20. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Exicure Inc. reported -$2.10 EPS against a consensus estimate of -$2.10. The surprise factor in the prior quarter was -$0.30. Based on analyst estimates, the high estimate for the next quarter is -$1.20 and the low estimate is -$1.20. The average estimate for the next quarter is thus -$1.20.
Summary of Insider Activity:
Insiders traded XCUR stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 1,472,126 shares were bought while 0 shares were sold. The number of buy transactions has increased to 4 while that of sell transactions has risen to 1 over the past year. The total number of shares bought during that period was 1,497,126 while 1,268,619 shares were sold.